(Q71160293)
Statements
Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group (English)
G V Campion
M E Lebsack
J Lookabaugh
G Gordon